ArticleEvidence-based complementary and alternative medicine : eCAM2022

Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer.

Dan Jian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.